๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Therapeutic antibody engineering : current and future advances driving the strongest growth area in the pharmaceutical industry

โœ Scribed by W R Strohl; Lila M Strohl


Publisher
Woodhead Publishing
Year
2013
Tongue
English
Leaves
229
Series
Woodhead publishing series in biomedicine, 11
Edition
1
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Therapeutic antibody engineering: Curren
โœ William Strohl, Lila Strohl ๐Ÿ“‚ Library ๐Ÿ“… 2012 ๐Ÿ› Woodhead Publishing ๐ŸŒ English

The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas.This book examines all aspects of engineering monoclonal an

Therapeutic Antibody Engineering. Curren
โœ W.R. Strohl and L.M. Strohl (Auth.) ๐Ÿ“‚ Library ๐Ÿ“… 2012 ๐Ÿ› Woodhead Publishing ๐ŸŒ English

The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of e

Leading Pharmaceutical Innovation: Trend
โœ Prof. Dr. Oliver Gassmann, Dr. Gerrit Reepmeyer, Prof. Dr. Maximilian von Zedtwi ๐Ÿ“‚ Library ๐Ÿ“… 2008 ๐Ÿ› Springer-Verlag Berlin Heidelberg ๐ŸŒ English

<p><P>Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating busine

Leading Pharmaceutical Innovation: Trend
โœ Prof. Dr. Oliver Gassmann, Dr. Gerrit Reepmeyer, Prof. Dr. Maximilian von Zedtwi ๐Ÿ“‚ Library ๐Ÿ“… 2008 ๐Ÿ› Springer-Verlag Berlin Heidelberg ๐ŸŒ English

<p><P>Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating busine